Statkraft and Elkem ASA have agreed on a seven-year power purchase agreement from 2031 to 2037, covering 1,534 GWh to supply Elkem’s Bjølvefossen plant in Norway. This deal ensures competitive and predictable electricity, supporting local jobs and sustainable production at one of the world’s largest foundry alloy suppliers. The agreement strengthens Elkem’s operational stability and investment planning, helping maintain industrial activity and contribute to EU's strategic material supply amid geopolitical uncertainties.
NRx Pharmaceuticals' stock fell 19.05% in after-hours trading following the announcement of a proposed underwritten public offering of common stock. The company plans to use the proceeds for working capital and general corporate purposes to support g...
Sigenergy has introduced SigenAgent, an AI-driven energy management system designed to optimize solar power, energy storage, and electric vehicle charging. Available globally through the mySigen App 4.0 as a software upgrade, SigenAgent allows users ...
Johnson & Johnson's investigational drug nipocalimab significantly reduced disease activity in adults with moderate-to-severe systemic lupus erythematosus (SLE) during a Phase 2 study, with effects sustained through 52 weeks. The drug targets pathoge...
SpaceX, led by Elon Musk, is targeting a $75 billion initial public offering (IPO) by selling 555.6 million shares at $135 per share. This move is unusual as the company has set a fixed share price before the typical investor roadshow. The IPO filing...
Novo Nordisk has launched the Wegovy pill in the United Arab Emirates, marking the first availability outside the US. The pill, containing semaglutide, is approved to reduce excess body weight by an average of 17% and lower the risk of major cardiova...
